Organogenesis Holdings Inc expected to post earnings of 1 cent a share - Earnings Preview

Organogenesis Holdings

27/02/2024 21:56

* Organogenesis Holdings Inc  ORGO.OQ   ORGO.O  is expected
to show a fall in quarterly revenue when it reports  results on
February 29 for the period ending December 31 2023
    * The Canton Massachusetts-based  company is expected to
report a
5.6% decrease in revenue to $109.05 million from $115.52 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Organogenesis Holdings
Inc is
for earnings of 1 cent per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
Organogenesis
Holdings Inc is $5.00​, above​ its last closing price of $3.49.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  0.00        0.01       0.02      Beat    300
 Jun. 30 2023  0.02        0.03       0.04      Beat    60
 Mar. 31 2023  -0.02       -0.02      -0.02     Met     0​
 Dec. 31 2022  0.05        0.05       0.06      Beat    20
 ​​Sep.        0.06        0.06       0.00      Missed  -100
 30 2022                                                
 Jun. 30 2022  0.08        0.08       0.07      Missed  -12.5​
 Mar. 31 2022  0.04        0.05       0.00      Missed  -100
 Dec. 31 2021  0.08        0.08       0.39      Beat    368
 This summary was machine generated February 27 at 21:56 GMT. 
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)